sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
24-Oct-2014 19:54
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 905.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 30-Jul-2014
Science Translational Medicine
New malaria vaccine candidates identified
New vaccine targets that could help in the battle against malaria have been discovered thanks to a new technique. Researchers tested a large library of proteins from the Plasmodium falciparum parasite with antibodies produced by the immune systems of a group of infected children to see which proteins would react. Using this large-scale approach, scientists found vaccine targets that have not been recognized before and identified combinations of antigens that could provide protection against malaria when used as a vaccine.
Wellcome Trust, Medical Research Council

Contact: Mary Clarke
press.office@sanger.ac.uk
01-223-492-368
Wellcome Trust Sanger Institute

Public Release: 30-Jul-2014
New England Journal of Medicine
Drug-resistant malaria has spread to critical border regions of Southeast Asia
Drug-resistant malaria parasites have spread to critical border regions of Southeast Asia, seriously threatening global malaria control and elimination programs, according to a study published in the New England Journal of Medicine.
UK Department for International Development, Worldwide Antimalarial Resistance Network, NIH/National Institute of Allergy and Infectious Diseases Intramural Research Program, Bill & Melinda Gates Foundation

Contact: Clare Ryan
c.ryan@wellcome.ac.uk
44-020-761-17262
Wellcome Trust

Public Release: 30-Jul-2014
Trends in Microbiology
Scientists call for new strategy in pursuit of HIV-free generation
In light of the recent news that HIV has been detected in the Mississippi baby previously thought to have been cured of the disease, researchers are assessing how to help those born to HIV-infected mothers. These infants around the world are in need of new immune-based protective strategies, including vaccines delivered to mothers and babies and the means to boost potentially protective maternal antibodies, say researchers writing in Trends in Microbiology on July 30.

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press

Public Release: 29-Jul-2014
New partnership to improve access to essential pain medications for people living with HIV
Today the Elizabeth Glaser Pediatric AIDS Foundation and the American Cancer Society announced a new partnership to improve access to essential pain medications for people living with HIV in Swaziland. As part of ACS' Treat the Pain initiative, this new partnership will help improve efforts to better integrate pain management into HIV/AIDS services throughout the country.

Contact: Johanna Harvey
jharvey@pedaids.org
202-280-1657
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 29-Jul-2014
PLOS Medicine
Urbanization of rural Africa associated with increased risk of heart disease and diabetes
The increasing urbanization of rural areas in sub-Saharan Africa could lead to an explosion in incidences of heart disease and diabetes, according to a new study carried out in Uganda which found that even small changes towards more urban lifestyles was associated with increased risk of cardiovascular and metabolic diseases.
African Partnership for Chronic Disease Research

Contact: Craig Brierley
craig.brierley@admin.cam.ac.uk
44-012-237-66205
University of Cambridge

Public Release: 29-Jul-2014
PLOS Medicine
Small increases in Ugandan urbanicity tied to CVD risk factors
Urban dwellers tend to have higher risk for cardiovascular diseases than people living in more rural locations. In a new study published in PLOS Medicine, Johanna Riha and colleagues have found that even within rural communities in Uganda that all lacked paved roads and running water, people living in villages with relatively more urban features were more likely to have risk factors for cardiovascular diseases such as physical inactivity, and high body mass index, even after controlling for socioeconomic status.
UK Medical Research Council

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 29-Jul-2014
PLOS Medicine
Malaria vaccine shows continued protection during 18 months of follow-up
A vaccine previously shown to reduce malaria in young infants and children reduces larger numbers of malaria cases in areas of higher malaria transmission, according to results from an ongoing clinical trial published in PLOS Medicine. The effect of vaccination diminished over time, but protection against clinical malaria remained evident 18 months after vaccination.
GSK Biologicals SA, PATH Malaria Vaccine Initiative

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 28-Jul-2014
Hepatology
Hepatitis C virus genotype 1 is most prevalent worldwide
In one of the largest prevalence studies to date, researchers from the UK provide national, regional, and global genotype prevalence estimates for the hepatitis C virus. Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 28-Jul-2014
American Journal of Tropical Medicine and Hygiene
First controlled malaria infection trial in Africa paves way for drug and vaccine development
An international research team today reports the first-ever clinical trial demonstrating controlled malaria infection in an African nation in the modern era. The study, published online in the American Journal of Tropical Medicine and Hygiene represents a significant milestone in the search for new malaria drugs and vaccines.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 24-Jul-2014
What constitutes an effective response to the global 'diabesity' tsunami?
This text describes the enormous global efforts expended in the attempt to prevent diabetes by implementing prevention programs in even the remotest communities. Although considerable progress is being made, clearly, much more needs to done. Effective coordination of governmental and non-governmental organizations, food and agricultural industries, regional and local health authorities, the practicing and academic medical communities is required with considerable investment of financial and other resources if the 'diabesity' tsunami is to be thwarted.

Contact: Jason Lim
cjlim@wspc.com.sg
65-646-65775 x247
World Scientific

Public Release: 24-Jul-2014
Cell
Mechanism found for development of protective HIV antibodies
Scientists at Duke Medicine have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 23-Jul-2014
ETH student develops filter for clean water around the world
An innovative filter makes it possible to purify water more quickly, simply and economically than ever before. The developers hope the device will soon play a big role development aid, and they are looking for investors to help them achieve this goal.

Contact: Media Releations ETH Zurich
mediareleations@hk.ethz.ch
41-446-324-141
ETH Zurich

Public Release: 21-Jul-2014
Nature Genetics
LSU's Mark Batzer contributes to Nature Genetics article on marmoset genome
LSU's Mark Batzer, Boyd Professor and Dr. Mary Lou Applewhite Distinguished Professor in Department of Biological Sciences in the College of Science, contributed to an article in the scientific journal Nature Genetics, titled 'The Common Marmoset Genome Provides Insight into Primate Biology and Evolution,' published on July 20.

Contact: Billy Gomila
bgomila@lsu.edu
225-578-3867
Louisiana State University

Public Release: 21-Jul-2014
Open Access Journal of Contraception
Communication about female condom vital to young adults, UT Arlington researchers say
UT Arlington communication researchers examine sexual health messages aimed at young college adults about the female condom.

Contact: Bridget Lewis
blewis@uta.edu
817-272-3317
University of Texas at Arlington

Public Release: 21-Jul-2014
The Lancet
Deaths and infections from HIV, tuberculosis, and malaria plummet globally
Today, fewer people are dying from HIV/AIDS, tuberculosis, and malaria, according to a new, first-of-its-kind analysis of trend data from 188 countries. The pace of decline in deaths and infections has accelerated since 2000, when the Millennium Development Goals were established to stop the spread of these diseases by 2015.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 21-Jul-2014
Proceedings of the National Academy of Sciences
Temple University researchers eliminate the HIV virus from cultured human cells for first time
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into its victims' DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers has designed a way to snip out the integrated HIV-1 genes for good.
National Institutes of Health

Contact: Jeremy Walter
Jeremy.Walter@tuhs.temple.edu
267-838-0398
Temple University Health System

Public Release: 17-Jul-2014
20th International AIDS Conference (AIDS 2014)
Biomarker discovery may lead to new HIV treatment
Further analysis of a Phase II study of therapeutic HIV vaccine candidate Vacc-4x revealed a potential biomarker associated with participants who experienced a more profound viral load reduction after receiving the vaccine. The results of this exploratory, ad hoc, subset analysis by St George's, University of London and Bionor Pharma were announced today at the AIDS 2014 Conference in Melbourne, Australia.
Bionor Pharma

Contact: David Sheon
dsheon@whitecoatstrategies.com
202-422-6999
WHITECOAT STRATEGIES, LLC

Public Release: 17-Jul-2014
Proceedings of the National Academy of Sciences
Eradicating fatal sleeping sickness by killing off the tsetse fly
Steven L. Peck, a BYU professor of biology, has lent his expertise in understanding insect movement to help shape a UN-sanctioned eradication effort of the tsetse fly -- a creature that passes the fatal African sleeping sickness to humans, domestic animals, and wildlife. Results of the effort appear in the Proceedings of the National Academy of Sciences.
US State Department, Joint Food and Agriculture Organization of the United Nations, International Atomic Energy Agency, Department of Technical Cooperation, Directorate of Veterinary Services of Senegal, Institut Senegalais de Recerches Agricoles

Contact: Todd Hollingshead
toddh@byu.edu
801-422-8373
Brigham Young University

Public Release: 16-Jul-2014
Analysis
Anti-tank missile detector joins the fight against malaria
State-of-the-art military hardware could soon fight malaria, one of the most deadly diseases on the planet. Researchers at Monash University and the University of Melbourne have used an anti-tank Javelin missile detector, more commonly used in warfare to detect the enemy, in a new test to rapidly identify malaria parasites in blood.

Contact: Lucy Handford
media@monash.edu
Monash University

Public Release: 16-Jul-2014
Food Control
Preventing foodborne illness, naturally -- with cinnamon
Cinnamomum cassia oil was shown to be effective as a natural antibacterial agent against several strains of Shiga toxin-producing Escherichia coli, known to the US Centers for Disease Control and Prevention as 'non-O157 STEC'. The study results add to a body of knowledge that will help improve food safety and reduce or eliminate cases of food poisoning and related deaths.

Contact: Meijun Zhu
meijun.zhu@wsu.edu
509-335-4016
Washington State University

Public Release: 15-Jul-2014
Talanta
New assay to spot fake malaria drugs could save thousands of lives
Chemists have created a new type of chemical test, or assay, that's inexpensive, simple, and can tell whether or not one of the primary drugs being used to treat malaria is genuine -- an enormous and deadly problem in the developing world. If widely used it could help save hundreds of thousands of lives.

Contact: Vincent Remcho
vincent.remcho@oregonstate.edu
541-737-8181
Oregon State University

Public Release: 15-Jul-2014
Nature Reviews Cardiology
Cardiac patients underserved globally due to lack of rehab programs: York University researcher
The article, Global availability of cardiac rehabilitation, published online at Nature Reviews Cardiology, indicates that while 68 per cent of high-income countries have cardiac rehabilitation, only 23 per cent of low-income and middle-income countries do, despite the fact that 80 per cent of deaths from heart disease occur in these countries.

Contact: Gloria Suhasini
suhasini@yorku.ca
416-736-2100 x22094
York University

Public Release: 15-Jul-2014
PLOS Medicine
Rollout strategy for diagnostic test in India may impact TB
Xpert MTB/RIF, a recently implemented tuberculosis (TB) test, has the potential to control the TB epidemic in India, but only if the current, narrow, implementation strategy is replaced by a more ambitious one that is better funded, also includes the private sector, and better referral networks are developed between public and private sectors, according to new research published in this week's PLOS Medicine.
Bill & Melinda Gates Foundation

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 14-Jul-2014
Emerging Infectious Diseases
Sierra Leone samples: Ebola evidence in West Africa in 2006
Analysis of clinical samples from suspected Lassa fever cases in Sierra Leone showed that about two-thirds of the patients had been exposed to other emerging diseases, and nearly nine percent tested positive for Ebola virus. The study, authored by USAMRIID and published in this month's edition of Emerging Infectious Diseases, demonstrates that Ebola virus has been circulating in the region since at least 2006 -- well before the current outbreak.
Armed Forces Health Surveillance Center, Global Emerging Infections Surveillance and Response System, US Department of Defense Cooperative Biological Engagement Program

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 10-Jul-2014
The Lancet
Injected vaccine could help eradicate polio
Re-introducing a type of polio vaccine that fell out of favor in the 1960s could hasten eradication of the disease, according to new research.
Bill & Melinda Gates Foundation

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London

Showing releases 151-175 out of 905.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>